Daniela Matei

  • 6985 Citations
  • 41 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Publications 1995 2019

4 Citations (Scopus)

Blockade of FGF signaling: Therapeutic promise for ovarian cancer

Ivan, M. & Matei, D., Sep 1 2010, In : Cancer Biology and Therapy. 10, 5, p. 505-508 4 p.

Research output: Contribution to journalComment/debate

Fibroblast Growth Factor Receptors
Fibroblast Growth Factors
Alternative Splicing
Antineoplastic Agents
Ovarian Neoplasms
1 Citation (Scopus)

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Dougherty, B., Orr, M., Hodgson, D., Barrett, J. C. & Matulonis, U., Jan 1 2015, In : Obstetrical and Gynecological Survey. 69, 10, p. 594-596 3 p.

Research output: Contribution to journalComment/debate

Ovarian Neoplasms

The hunt for elusive cancer stem cells

Condello, S., Nwani, N. G. & Matei, D., 2017, In : Oncotarget. 8, 24, p. 38076-38077 2 p.

Research output: Contribution to journalComment/debate

Neoplastic Stem Cells
transglutaminase 2